Introduction of protein kinase recognition sites into proteins: A review of their preparation, advantages, and applications

Protein Expression and Purification

Volumn 17, Issue 2, 1999, Pages 203-214

  Pestka, Sidney ^a,b   Lin, Lei ^a,b   Wu, Wei ^a,b   Izotova, Lara ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE; PROTEIN LABELLING;

EID: 0033229889     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1999.1118     Document Type: Review

References (74)

1. Li B. L., Langer J. A., Schwartz B., Pestka S. Creation of phosphorylation sites in proteins: Construction of a phosphorylatable human interferon alpha. Proc. Natl. Acad. Sci. USA. 86:1989;558-562.
2. Wang P., Izotova L., Mariano T. M., Donnelly R. J., Pestka S. Construction and activity of phosphorylatable human interferon-alpha B2 and interferon-alpha A/D. J. Interferon Res. 14:1994;41-46.
3. Zhao X. X., Li B. L., Langer J. A., Van Riper G., Pestka S. Construction and phosphorylation of a fusion protein Hu-IFN-α A/γ Anal. Biochem. 178:1989;342-347.
4. Lin L., Daugherty B., Schlom J., Pestka S. Construction of phosphorylatable monoclonal antibody to a tumor-associated antigen. Cancer Res. 56:1996;4250-4254.
5. Lin L., Gillies S. D., Lan Y., Izotova L., Wu W., Schlom J., Pestka S. Construction of phosphorylatable chimeric monoclonal antibody CC49. Int. J. Oncol. 13:1998;115-120.
6. Lin L., Gillies S. D., Schlom J., Pestka S. Construction of phosphorylatable chimeric monoclonal antibody CC49 with a casein kinase I recognition site. Protein Expression Purif. 15:1999;83-91.
7. Lin L., Gillies S. D., Schlom J., Pestka S. Construction of phosphorylatable monoclonal antibody CC49 with a casein kinase II recognition site. Anticancer Res. 18:1998;3971-3978.
8. Lin L., Gillies S. D., Schlom J., Pestka S. Construction of phosphorylatable chimeric monoclonal antibody CC49 with a tyrosine Src kinase recognition site. Int. J. Oncol. 13:1998;725-732.
9. Goldenberg D. M. Monoclonal antibodies in cancer detection and therapy. Am. J. Med. 94:1993;297-312.
10. Schlom J. Monoclonal antibodies in cancer therapy. Devita V. T., Hellman S., Rosenberg S. A. Biological Therapy of Cancer. 1995;507-521 Lippincott, Philadelphia.
11. 32P. Br. J. Cancer. 57:1988;489-493.
12. Dagan S., Tzehoval E., Fridkin M., Feldman M. Tuftsin and tuftsin conjugates potentiate immunogenic processes: Effects and possible mechanisms. J. Biol. Response Mod. 6:1987;625-636.
13. Hunter T., Sefton B. M. Protein phosphorylation, part A. Methods Enzymol. 200:1991;1-763.
14. Hunter T., Sefton B. M. Protein phosphorylation, part B. Methods Enzymol. 201:1991;1-547.
15. Adams P. D., Li X., Sellers W. R., Baker K. B., Leng X., Harper J. W., Taya Y., Kaelin W. G. J. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol. Cell. Biol. 19:1999;1068-1080.
16. Ashkar S., Teplow D. B., Glimcher M. J., Saavedra R. A. In vitro phosphorylation of mouse osteopontin expressed in E. coli. Biochem. Biophys. Res. Commun. 191:1993;126-133.
17. Blanar M. A., Rutter W. J. Interaction cloning: Identification of a helix-loop-helix zipper protein that interacts with c-Fos. Science. 256:1992;1014-1018.
18. 32P-labeled GST-calmodulin fusion protein and a novel renaturation protocol. Biotechniques. 21:1996;292-296.
19. Kaelin W. G. J., Krek W., Sellers W. R., DeCaprio J. A., Ajchenbaum F., Fuchs C. S., Chittenden T., Li Y., Farnham P. J., Blanar M. A. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell. 70:1992;351-364.
20. Mohanraj D., Wahlsten J. L., Ramakrishnan S. Expression and radiolabeling of recombinant proteins containing a phosphorylation motif. Protein Expression Purif. 8:1996;175-182.
21. Fryxell D., Li B. Y., Mohanraj D., Johnson B., Ramakrishnan S. Genetic construction of a phosphorylation site in ricin A chain: Specific radiolabeling of recombinant proteins for localization and degradation studies. Biochem. Biophys. Res. Commun. 210:1995;253-259.
22. Moss S. J., Doherty C. A., Huganir R. L. Identification of the cAMP-dependent protein kinase and protein kinase C phosphorylation sites within the major intracellular domains of the beta 1, gamma 2S, and gamma 2L subunits of the gamma-aminobutyric acid type A receptor. J. Biol. Chem. 267:1992;14470-14476.
23. 32P]-ATP. Nat. Biotechnol. 14:1996;485-490.
24. Ron D., Dressler H. pGSTag - A versatile bacterial expression plasmid for enzymatic labeling of recombinant proteins. Biotechniques. 13:1992;866-869.
25. Stofko-Hahn R. E., Carr D. W., Scott J. D. A single step purification for recombinant proteins. Characterization of a microtubule associated protein (MAP 2) fragment which associates with the type II cAMP-dependent protein kinase. FEBS Lett. 302:1992;274-278.
26. Zamanillo D., Casanova E., Alonso-Llamazares A., Ovalle S., Chinchetru M. A., Calvo P. Identification of a cyclic adenosine 3′,5′-monophosphate-dependent protein kinase phosphorylation site in the carboxy terminal tail of human D1 dopamine receptor. Neurosci. Lett. 188:1995;183-186.
27. 70 binding site on the N terminus of the Escherichia coli RNA polymerase β′ subunit. J. Biol. Chem. 273:1998;31381-31387.
28. 6-tagged protein fusions. Methods Enzymol. 2000.
29. Edelman A. M., Blumenthal D. K., Krebs E. G. Protein serine/threonine kinases. Annu. Rev. Biochem. 56:1987;567-613.
30. Glass D. B., Krebs E. G. Protein phosphorylation catalyzed by cyclic AMP-dependent and cyclic GMP-dependent protein kinases. Annu. Rev. Pharmacol. Toxicol. 20:1980;363-388.
31. Hunter T., Cooper J. A. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:1985;897-930.
32. Kemp B. E., Pearson R. B. Protein kinase recognition sequence motifs. Trends. Biochem. Sci. 15:1990;342-346.
33. Krebs E. G., Beavo J. A. Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 48:1979;923-959.
34. Pearson R. B., Kemp B. E. Protein kinase phosphorylation site sequences and consensus specificity motifs: Tabulations. Methods Enzymol. 200:1991;62-81.
35. Zetterqvist O., Ragnarsson U. The structural requirements of substrates of cyclic AMP-dependent protein kinase. FEBS Lett. 139:1982;287-290.
36. Marchiori F., Meggio F., Marin O., Borin G., Calderan A., Ruzza P., Pinna L. A. Synthetic peptide substrates for casein kinase 2. Assessment of minimum structural requirements for phosphorylation. Biochim. Biophys. Acta. 971:1988;332-338.
37. Marin O., Meggio F., Marchiori F., Borin G., Pinna L. A. Site specificity of casein kinase-2 (TS) from rat liver cytosol. A study with model peptide substrates. Eur. J. Biochem. 160:1986;239-244.
38. Marin O., Calderan A., Ruzza P., Borin G., Meggio F., Grankowski N., Marchiori F. Synthetic peptides including acidic clusters as substrates of yeast casein kinase-2. Int. J. Pept. Protein Res. 36:1990;374-380.
39. Meggio F., Perich J. W., Reynolds E. C., Pinna L. A. A synthetic beta-casein phosphopeptide and analogues as model substrates for casein kinase-1, a ubiquitous, phosphate directed protein kinase. FEBS Lett. 283:1991;303-306.
40. Kemp B. E., Graves D. J., Benjamini E., Krebs E. G. Role of multiple basic residues in determining the substrate specificity of cyclic AMP-dependent protein kinase. J. Biol. Chem. 252:1977;4888-4894.
41. Cook J. R., Cleary C. M., Mariano T. M., Izotova L., Pestka S. Differential responsiveness of a splice variant of the human type I interferon receptor to interferons. J. Biol. Chem. 271:1996;13448-13453.
42. Flores I., Mariano T. M., Pestka S. Human interferon ω (ω) binds to the alpha/beta receptor. J. Biol. Chem. 266:1991;19875-19877.
43. Pestka S. The interferon receptors. Semin. Oncol. 24:1997;S9-18-S9-40.
44. Soh J., Mariano T. M., Lim J. K., Izotova L., Mirochnitchenko O., Schwartz B., Langer J. A., Pestka S. Expression of a functional human type I interferon receptor in hamster cells: Application of functional yeast artificial chromosome (YAC) screening. J. Biol. Chem. 269:1994;18102-18110.
45. Alexenko A. P., Li J., Mathialagan N., Izotova L., Mariano T. M., Pestka S., Roberts R. M. Interaction of bovine interferon-τ with the type I interferon receptor on Daudi cells. J. Interferon Cytokine Res. 15:1995;S97.
46. Xiao C. Y., Hubner S., Elliot R. M., Caon A., Jans D. A. A consensus cAMP-dependent protein kinase (PK-A) site in place of the CcN motif casein kinase II site simian virus 40 large T-antigen confers PK-A-mediated regulation of nuclear import. J. Biol. Chem. 271:1996;6451-6457.
47. Neri D., Natali P. G., Petrul H., Soldani P., Nicotra M. R., Vola R., Rivella A., Creighton A. M., Neri P., Mariani M. Recombinant anti-human melanoma antibodies are versatile molecules. J. Invest. Dermatol. 107:1996;164-170.
48. Pestka S. Studies in transfer ribonucleic acid-ribosome complex. J. Biol. Chem. 247:1972;4669-4678.
49. Pestka S., Lin L., Wu W., Izotova L. Use of phosphorylation tags in proteins. Methods Enzymol. 2000.
50. Scatchard G. Attraction of proteins for small molecules and ions. Ann. N. Y. Acad. Sci. 51:1949;660-672.
51. Fields R., Mariano T. M., Stein S., Pestka S. Recombinant rat and murine immune interferons are phosphorylated at a single site, Ser132. J. Interferon Res. 8:1987;549-557.
52. Hibino Y., Mariano T. M., Kumar C. S., Kozak C. A., Pestka S. Expression and reconstitution of a biologically active mouse interferon gamma receptor in hamster cells: Chromosomal location of an accessory factor. J. Biol. Chem. 266:1991;6948-6951.
53. Hibino Y., Kumar C. S., Mariano T. M., Lai D., Pestka S. Chimeric interferon gamma receptors demonstrate that an accessory factor required for activity interacts with the extracellular domain. J. Biol. Chem. 267:1992;3741-3749.
54. Jung V., Rashidbaigi A., Jones C., Tischfield J. A., Shows T. B., Pestka S. Human chromosomes 6 and 21 are required for sensitivity to human interferon gamma. Proc. Natl. Acad. Sci. USA. 84:1987;4151-4155.
55. Jung V., Jones C., Rashidbaigi A., Geyer D. D., Morse H. G., Wright R. B., Pestka S. Chromosome mapping of biological pathways by fluorescence-activated cell sorting and cell fusion: The human interferon gamma receptor as a model system. Somatic Cell Mol. Genet. 14:1988;583-592.
56. Jung V., Jones C., Kumar C. S., Stefanos S., O'Connell S., Pestka S. Expression and reconstitution of a biologically active human interferon gamma receptor in hamster cells. J. Biol. Chem. 265:1990;1827-1830.
57. Kotenko S. V., Izotova L. S., Pollack B. P., Mariano T. M., Donnelly R. J., Muthukumaran G., Cook J. R., Garotta G., Silvennoinen O., Ihle J. N., Pestka S. Interaction between the components of the interferon gamma receptor complex. J. Biol. Chem. 270:1995;20915-20921.
58. Kotenko S. V., Izotova L. S., Pollack B. P., Muthukumaran G., Paukku K., Silvennoinen O., Ihle J. N., Pestka S. Other kinases can substitute for Jak2 in signal transduction by IFN-γ J. Biol. Chem. 271:1996;17174-17182.
59. Kumar C. S., Mariano T. M., Noe M., Deshpande A. K., Rose P. M., Pestka S. Expression of the murine interferon γ receptor in Xenopus laevis oocytes. J. Biol. Chem. 263:1988;13493-13496.
60. Kumar C. S., Muthukumaran G., Frost L. J., Noe M., Ahn Y.-H., Mariano T. M., Pestka S. Molecular characterization of the murine interferon gamma receptor cDNA. J. Biol. Chem. 264:1989;17939-17946.
61. 32P-labeled human immune interferon, Int. Soc. Interferon Res. Clearwater Beach, FL, October 13, 1985.
62. Langer J. A., Pestka S. Changes in binding of alpha interferon IFN-αA to HL-60 cells during myeloid differentiation. J. Interferon Res. 5:1985;637-649.
63. Langer J. A., Pestka S. Procedures for studying binding of interferon to human cells in suspension cultures. Methods Enzymol. 119:1986;305-311.
64. 32P-labeled murine immune interferon and its binding to the mouse immune interferon receptor. J. Biol. Chem. 21:1986;9801-9804.
65. Mariano T. M., Kozak C. A., Langer J. A., Pestka S. The mouse immune interferon receptor gene is located on chromosome 10. J. Biol. Chem. 262:1987;5812-5814.
66. Mariano T. M., Izotova L., Pestka S. Receptor binding studies. Balkwill F. R. Cytokines - A Practical Approach. 1994;77-91 Oxford Univ. Press, London.
67. 32P-labeled human recombinant immune interferon. J. Biol. Chem. 260:1985;8514-8519.
68. Rashidbaigi A., Langer J. A., Jung V., Jones C., Morse H. G., Tischfield J. A., Trill J. J., Kung H.-F., Pestka S. The gene for the human immune interferon receptor is located on chromosome 6. Proc. Natl. Acad. Sci. USA. 83:1986;384-388.
69. 32P-labeled human recombinant immune interferon to U937 cells. Methods Enzymol. 119:1986;315-321.
70. Rashidbaigi A., Stefanos S., Jung V., Langer J. Immune interferon receptor: Chemical and enzymatic sensitivity. J. Interferon Res. 8:1988;641-654.
71. Stefanos S., Ahn Y. H., Pestka S. Characterization of human interferon-γ receptor purified from placenta. J. Interferon Res. 9:1989;719-730.
72. Stefanos S., Pestka S. A convenient assay for detection of soluble interferon receptors. J. Biol. Regul. Homeostatic Agents. 4:1990;57-59.
73. Kung H.-F., Bekesi E. Phosphorylation of human immune interferon (IFN-γ). Methods Enzymol. 119:1986;296-301.
74. Cheng H. C., Nishio H., Hatase O., Ralph S., Wang J. H. A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases. J. Biol. Chem. 267:1992;9248-9256.